Pharmacovigilance Polaris Alpha

Access and review therapeutic indications and adverse reactions reported on Summary of Product Characteristics (SmPCs) encoded as MedDRA Lowest Level Terms (LLTs).

This product is under development and will be released in summer 2023. In the meantime, you may contact us to know more about our data integration service for encoding your own SmPC data set.

MedBrains — © 2018-2023

We are an all-remote company: find out more about us!

Registered office:
Stradone Porta Palio 82/A, 37122 Verona, Italy.
Fully paid-up share capital: 10.000 euro.
Fiscal code and VAT number: 04554160236.
REA number: VR 430190.